Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism (2005)
- Authors:
- USP affiliated authors: GERLACH, RAQUEL FERNANDA - FORP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: FORP; FMRP
- Assunto: EMBOLIA
- Language: Inglês
- Imprenta:
- Source:
-
ABNT
PALEI, Ana C. T. et al. Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism. Angiology, v. 56, n. 5, p. 611-617, 2005Tradução . . Acesso em: 15 jan. 2026. -
APA
Palei, A. C. T., Zaneti, R. A. G., Fortuna, G. M., Gerlach, R. F., & Tanus-Santos, J. E. (2005). Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism. Angiology, 56( 5), 611-617. -
NLM
Palei ACT, Zaneti RAG, Fortuna GM, Gerlach RF, Tanus-Santos JE. Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism. Angiology. 2005 ; 56( 5): 611-617.[citado 2026 jan. 15 ] -
Vancouver
Palei ACT, Zaneti RAG, Fortuna GM, Gerlach RF, Tanus-Santos JE. Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism. Angiology. 2005 ; 56( 5): 611-617.[citado 2026 jan. 15 ] - The nuclear factor kappaB inhibitor pyrrolidine dithiocarbamate prevents cardiac remodelling and matrix metalloproteinase-2 up-regulation in renovascular hypertension
- Inibição de metaloproteinases (MMPs) com Doxycycline atenua a embolia pulmonar aguda (EPA)-indutor de hipotensão sistêmica
- Nicotine accutely increases plasma MMP-9 activity
- Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells
- Determinação de gelatinases no fluido gengival em pacientes sadios e com doença periodontal
- Atorvastatin and sildenafil reduce vascular remodeling and oxidative stress in 2K1C-hypertension
- Antioxidant treatment protects against matrix metalloproteinases activation and cardiomyocyte injury during acute pulmonary thromboembolism
- Nitric oxide attenuates matrix metalloproteinase-9 production by endothelial cells
- Antioxidant treatment protects against matrix metalloproteinase activation and cardiomyocyte injury during care pulmonary thromboembolism
- Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
